Zobrazeno 1 - 10
of 106
pro vyhledávání: '"Tiana Le"'
Autor:
Melissa Pilewskie, Varadan Sevilimedu, Idil Eroglu, Tiana Le, Rui Wang, Monica Morrow, Lior Z. Braunstein
Publikováno v:
Annals of Surgical Oncology. 29:6267-6273
Autor:
Linda M. Pak, Kate R. Pawloski, Varadan Sevilimedu, Hannah L. Kalvin, Tiana Le, Hanae K. Tokita, Audree Tadros, Monica Morrow, Kimberly J. Van Zee, Laurie J. Kirstein, Tracy-Ann Moo
Publikováno v:
Annals of Surgical Oncology. 29:6706-6713
Autor:
Melissa, Pilewskie, Varadan, Sevilimedu, Idil, Eroglu, Tiana, Le, Rui, Wang, Monica, Morrow, Lior Z, Braunstein
Publikováno v:
Annals of surgical oncology. 29(10)
Autor:
Astrid Botty Van den Bruele, Tiana Le, Monica Fornier, Varadan Sevilimedu, Monica Morrow, Emanuela Ferraro, Molly P Hogan, Virgilio Sacchini, Sidra Javed-Tayyab
Publikováno v:
Breast Cancer Research and Treatment. 189:307-315
HER2 +- amplified breast cancer patients derive benefit from treatment with anti-HER2-targeted therapy. Though adjuvant treatment is based on final pathology, decisions regarding neoadjuvant chemotherapy are made in the preoperative setting with imag
Autor:
Ishita Chen, Hiram S. Cody, Tiana Le, Lior Z. Braunstein, Varadan Sevilimedu, Monica Morrow, Astrid Botty Van den Bruele
Publikováno v:
Breast Cancer Research and Treatment. 187:105-112
Breast conservation therapy (BCT) is well established for the management of primary operable breast cancer, with oncologic outcomes comparable to those of mastectomy. It remains unclear whether re-conservation therapy (RCT) is suitable for those pati
Autor:
Linda M, Pak, Kate R, Pawloski, Varadan, Sevilimedu, Hannah L, Kalvin, Tiana, Le, Hanae K, Tokita, Audree, Tadros, Monica, Morrow, Kimberly J, Van Zee, Laurie J, Kirstein, Tracy-Ann, Moo
Publikováno v:
Annals of Surgical Oncology. 29:6714-6715
Publikováno v:
Cancer
BACKGROUND In early studies, local recurrence (LR) rates were higher after neoadjuvant chemotherapy (NAC) in comparison with upfront surgery. Modern outcomes are uncertain, particularly among those who are initially breast-conserving surgery-ineligib
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::39e4179017d49753bfe9e1505153097e
https://europepmc.org/articles/PMC8776569/
https://europepmc.org/articles/PMC8776569/
Autor:
Regina Matar, Andrea V. Barrio, Varadan Sevilimedu, Tiana Le, Alexandra Heerdt, Monica Morrow, Audree Tadros
Publikováno v:
Annals of surgical oncology. 29(4)
Omission of sentinel lymph node biopsy (SLNB) in older women with clinically node-negative, hormone receptor-positive (HR+) early-stage breast cancer undergoing lumpectomy is accepted, given established low rates of regional recurrence. The safety of
Autor:
Regina Matar, Andrea V. Barrio, Varadan Sevilimedu, Tiana Le, Alexandra Heerdt, Monica Morrow, Audree Tadros
Publikováno v:
Annals of Surgical Oncology. 29:2273-2274
Autor:
Minna K. Lee, Robyn Rubenstein, Varadan Sevilimedu, Giacomo Montagna, Meghana Shamsunder, Jonas A. Nelson, Tiana Le, Paula Garcia, Monica Morrow, Audree Tadros
Publikováno v:
Journal of Clinical Oncology. 40:e12575-e12575
e12575 Background: Randomized trials have shown no difference in outcomes for cT1-2N0 breast cancer patients with 1-2+ sentinel lymph nodes (SLNs) undergoing sentinel lymph node biopsy (SLNB) alone compared to axillary dissection (ALND). No studies h